Compstatin analogs with improved pharmacokinetic properties
AssigneeThe Trustees of the University of Pennsylvania
InventorsJohn D. Lambris, Hongchang Qu, Daniel Ricklin
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Trustees of the University of Pennsylvania
InventorsJohn D. Lambris, Hongchang Qu, Daniel Ricklin
Estimating the term…
Compounds comprising peptides capable of binding C3 protein and inhibiting complement activation are disclosed. The compounds comprise compstatin analogs in which the N-terminus contains an added or substituted component that improves (1) the peptide's binding affinity to C3 or its fragments, (2) the peptide's solubility in aqueous liquids, (3) the peptide's plasma stability, (4) the peptide's in vivo retention and/or (5) the peptide's bioavailability, as compared with an unmodified compstatin peptide under equivalent conditions. Pharmaceutical compositions and methods of using the compounds are also disclosed.
A method of making a compound comprising a peptide having a sequence of SEQ ID NO:29, which is:
A compound comprising a peptide having a sequence of SEQ ID NO:29, which is:
A compound comprising a peptide having a sequence of SEQ ID NO:29, which is:
A compound comprising a peptide having a sequence of SEQ ID NO:29, which is:
Dependencies are inferred from the claim text.